These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Effects of preoperative transcatheter artery chemoembolization on survival rate of hepatoma with percutaneous radiofrequency ablation]. Zhou DW; Zhang ZJ; Sun W Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(11):786-8. PubMed ID: 15949389 [No Abstract] [Full Text] [Related]
24. [Percutaneous tumor ablation therapy for hepatocellular carcinoma: current status and future perspective]. Shina S Nihon Shokakibyo Gakkai Zasshi; 2001 Jul; 98(7):809-13. PubMed ID: 11510082 [No Abstract] [Full Text] [Related]
25. Transcatheter chemoembolization of unresectable hepatocellular carcinoma: current knowledge and future directions. Maleux G; van Malenstein H; Vandecaveye V; Heye S; Vaninbroukx J; Nevens F; Verslype C Dig Dis; 2009; 27(2):157-63. PubMed ID: 19546554 [TBL] [Abstract][Full Text] [Related]
26. [Annoted analysis of the article: chemoembolization combined with radiofrequency ablation for patients with hepatocellular carcinoma larger than 3 cm. A randomized controlled trial]. Aubé C J Radiol; 2008 Sep; 89(9 Pt 1):1050-2. PubMed ID: 18772782 [No Abstract] [Full Text] [Related]
27. Radiofrequency ablation with or without transcatheter arterial chemoembolization. Palmer DH J Clin Oncol; 2013 Jul; 31(21):2756. PubMed ID: 23733766 [No Abstract] [Full Text] [Related]
33. [Management of complications associated with local ablation therapy for hepatocellular carcinoma]. Obi S; Shiina S; Imamura M; Teratani T; Satoh S; Koike Y; Ishikawa T; Akamatsu M; Fujishima T; Tateishi R; Omata M Nihon Rinsho; 2001 Oct; 59 Suppl 6():606-11. PubMed ID: 11762021 [No Abstract] [Full Text] [Related]
34. Liver-directed therapy for hepatocellular carcinoma. Narsinh KH; Duncan DP; Newton IG; Minocha J; Rose SC Abdom Radiol (NY); 2018 Jan; 43(1):203-217. PubMed ID: 29230556 [TBL] [Abstract][Full Text] [Related]
35. Complication rates of ablation therapies for hepatocellular carcinoma: a difficult comparison with an easy solution. Arienti V; Pretolani S Gut; 2006 Aug; 55(8):1211-2. PubMed ID: 16849356 [No Abstract] [Full Text] [Related]
36. The use of transarterial chemoembolization in hepatiocellular carcinoma 2 cm or smaller. Lo GH Am J Gastroenterol; 2015 Jan; 110(1):196. PubMed ID: 25567178 [No Abstract] [Full Text] [Related]
37. [Transcatheter arterial embolization therapy and local ablation]. Tanaka S; Hamuro M; Nishida N; Kaminou T; Matsuoka T; Nakamura K; Yamada R Nihon Rinsho; 2001 Oct; 59 Suppl 6():721-5. PubMed ID: 11762045 [No Abstract] [Full Text] [Related]
38. Transcatheter arterial chemoembolization therapy combined with percutaneous ethanol injection for unresectable large hepatocellular carcinoma: an evaluation of the local therapeutic effect and survival rate. Dohmen K; Shirahama M; Shigematsu H; Miyamoto Y; Torii Y; Irie K; Ishibashi H Hepatogastroenterology; 2001; 48(41):1409-15. PubMed ID: 11677976 [TBL] [Abstract][Full Text] [Related]
39. Transarterial chemoembolization and percutaneous ethanol injection therapy in patients with hepatocellular carcinoma. Kirchhoff T; Chavan A; Galanski M Eur J Gastroenterol Hepatol; 1998 Nov; 10(11):907-9. PubMed ID: 9872610 [TBL] [Abstract][Full Text] [Related]
40. [Discusses on the multimodality therapy of hepatocellular carcinoma]. Dou KF; Li BD Zhonghua Wai Ke Za Zhi; 2006 Aug; 44(15):1011-4. PubMed ID: 17074233 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]